IP Library › Granted Patent US 12,727,930
Granted Patent B2
US 12,727,930 · App. 18/776,154 · Granted Sep 8, 2026

Systems, devices, and methods for ablation and defunctionalization of a gallbladder

Inventors: Matthew Nojoomi (Houston, TX); David Waters (Houston, TX); Aedan Mangan (Cleveland, OH); Eric Ryba (Durango, CO); Michael Mulanix (Lakewood, CO)
Assignee: Ictero Medical, Inc.
A61B18/0218A61B2017/00336A61B2018/0016A61B2018/00214A61B2018/00535A61B2018/00577A61B2018/00642A61B2018/00791A61B2018/0212
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,727,930
App. No.
18/776,154
Granted
Sep 8, 2026
Kind
B2
Abstract

Provided herein are catheter devices, systems, and methods to ablate a tissue location. The devises, systems, and methods disclosed herein include ablation systems including a catheter system with inner and outer shafts that deliver an ablation medium (e.g., a cryogenic ablation medium) to a body lumen and evacuate the ablation medium from the body lumen. In some embodiments, devices, systems, and methods disclose herein include expandable structures that facilitate in positioning of nozzles and/or evacuation of ablation medium from a body lumen.

Claims (27)

1 . A method, comprising:

transitioning a first expandable body disposed on a distal end of a first shaft into an expanded configuration to retain the distal end of the first shaft within a gallbladder lumen of a subject, the first shaft defining a first lumen;

advancing a distal portion of a second shaft through the first lumen and into the gallbladder lumen, the second shaft defining a second lumen that terminates at a plurality of nozzle openings disposed on the distal portion of the second shaft;

transitioning a second expandable body disposed on the distal portion of the second shaft into a deployed configuration to position the plurality of nozzle openings at a minimum radial distance away from a wall of the gallbladder lumen;

delivering, via the second lumen and the plurality of nozzle openings, and after transitioning the second expandable body, a cryogenic ablation medium into the gallbladder lumen such that the cryogenic ablation medium can contact and ablate the wall of the gallbladder lumen;

evacuating, via an evacuation path defined in part by one or both of the first and second shafts, fluids from within the gallbladder lumen while delivering the cryogenic ablation medium;

measuring an intraluminal pressure of the gallbladder lumen via a pressure sensor operatively coupled to a pressure sensing lumen defined within the first shaft, the pressure sensing lumen having a distal opening that is communicatively coupled to the gallbladder lumen when the distal end of the first shaft is disposed in the gallbladder lumen;

controlling the delivery of the cryogenic ablation medium based on the intraluminal pressure of the gallbladder lumen; and

heating, using a heating element, at least a portion of the evacuation path to reduce formation of ice within the evacuation path.

2 . The method of claim 1 , further comprising:

measuring a temperature of the wall of the gallbladder lumen using a temperature sensor; and

confirming whether the wall of the gallbladder lumen has been ablated based on the temperature.

3 . A method, comprising:

transitioning a retention mechanism disposed on a distal end of an introducer into an expanded configuration to retain a distal tip of an introducer within a gallbladder of a subject;

advancing a distal end of an ablation catheter into the gallbladder via a lumen of the introducer, the ablation catheter defining a second lumen and including a plurality of nozzle openings and an expandable body disposed on the distal end of the ablation catheter, the expandable body formed of a plurality of elongate members;

transitioning the expandable body into a deployed configuration such that the plurality of elongate members expand outward from a longitudinal axis of the ablation catheter to position the plurality of nozzle openings at least a predetermined distance from a wall of the gallbladder;

conveying, via the second lumen, a cryogenic ablation fluid to the plurality of nozzle openings;

dispensing the cryogenic ablation fluid from the plurality of nozzle openings in a spray pattern to cause the cryogenic ablation fluid to contact the wall of the gallbladder and phase change into a cryogenic ablation gas;

measuring an intraluminal pressure of the gallbladder via a pressure sensor operatively coupled to a pressure sensing lumen defined within the ablation catheter, the pressure sensing lumen having a distal opening that is communicatively coupled to the gallbladder when the distal end of the ablation catheter is disposed in the gallbladder; and

controlling the dispensing of the cryogenic ablation fluid based on the intraluminal pressure of the gallbladder lumen.

4 . The method of claim 3 , further comprising:

evacuating at least a portion of the cryogenic ablation gas from the gallbladder via the first lumen.

5 . The method of claim 4 , further comprising:

heating, using a heating element of the ablation catheter, at least a portion of the length of the introducer to prevent clogging during the evacuation.

6 . The method of claim 3 , further comprising:

measuring a temperature of the wall of the gallbladder using a temperature sensor; and

confirming whether the wall of the gallbladder has been ablated based on the temperature.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2025
From: NOJOOMI, MATTHEW; WATERS, DAVID; MANGAN, AEDAN; RYBA, ERIC; MULANIX, MICHAEL
To: ICTERO MEDICAL, INC.
Reel/Frame 069908/0784 →
Continuity (4)
Division 18108831 · Feb 13, 2023
Continuation PCTUS2021045987 · Aug 13, 2021
Provisional Application 63066005 · Aug 14, 2020
Related Publication 20250082388A1 · Mar 13, 2025
References Cited (178)
US 4696668A · Wilcox · 1987 [cited by applicant]
US 4781677A · Wilcox · 1988 [cited by applicant]
US 4979948A · Geddes et al. · 1990 [cited by applicant]
US 5045056A · Behl · 1991 [cited by applicant]
US 5100388A · Behl et al. · 1992 [cited by applicant]
US 5159925A · Neuwirth et al. · 1992 [cited by applicant]
US 5183464A · Dubrul et al. · 1993 [cited by applicant]
US 5188602A · Nichols · 1993 [cited by applicant]
US 5213571A · Fujio et al. · 1993 [cited by applicant]
US 5452582A · Longsworth · 1995 [cited by applicant]
US 5501681A · Neuwirth et al. · 1996 [cited by applicant]
US 5891134A · Goble et al. · 1999 [cited by applicant]
US 6077261A · Behl et al. · 2000 [cited by applicant]
US 6245064B1 · Lesh et al. · 2001 [cited by applicant]
US 6283959B1 · Lalonde et al. · 2001 [cited by applicant]
US 6383181B1 · Johnston et al. · 2002 [cited by applicant]
US 6494844B1 · Van et al. · 2002 [cited by applicant]
US 6517533B1 · Swaminathan · 2003 [cited by applicant]
US 6575966B2 · Lane et al. · 2003 [cited by applicant]
US 6599299B2 · Schultz · 2003 [cited by applicant]
US 6623479B1 · Nun · 2003 [cited by applicant]
US 7025762B2 · Johnston et al. · 2006 [cited by applicant]
US 8048101B2 · Lee-Sepsick et al. · 2011 [cited by applicant]
US 8062282B2 · Kolb · 2011 [cited by applicant]
US 8327852B2 · Nikolchev et al. · 2012 [cited by applicant]
US 8382746B2 · Williams et al. · 2013 [cited by applicant]
US 8663211B2 · Fourkas et al. · 2014 [cited by applicant]
US 9144449B2 · Burr et al. · 2015 [cited by applicant]
US 9168081B2 · Williams et al. · 2015 [cited by applicant]
US 9282968B2 · Van Dam et al. · 2016 [cited by applicant]
US 9301796B2 · Burr et al. · 2016 [cited by applicant]
US 9326757B2 · Ravikumar et al. · 2016 [cited by applicant]
US 9486219B2 · Van et al. · 2016 [cited by applicant]
US 9757535B2 · Rajagopalan et al. · 2017 [cited by applicant]
US 9820797B2 · Burr et al. · 2017 [cited by applicant]
US 9844641B2 · Rajagopalan et al. · 2017 [cited by applicant]
US 9931152B2 · Wittenberger et al. · 2018 [cited by applicant]
US 10004550B2 · Ryba et al. · 2018 [cited by applicant]
US 10383676B2 · Williams et al. · 2019 [cited by applicant]
US 10610663B2 · Rajagopalan et al. · 2020 [cited by applicant]
US 10980590B2 · Rajagopalan et al. · 2021 [cited by applicant]
US 10993827B2 · Kim · 2021 [cited by applicant]
US 11026738B2 · Saadat et al. · 2021 [cited by applicant]
US 11033319B2 · Kochavi · 2021 [cited by applicant]
US 11185360B2 · Mulcahey · 2021 [cited by applicant]
US 11207117B2 · McDermott et al. · 2021 [cited by applicant]
US 11259857B2 · Lalonde · 2022 [cited by applicant]
US 11259858B1 · Rahimzadeh et al. · 2022 [cited by applicant]
US 11364065B2 · Downey et al. · 2022 [cited by applicant]
US 12070257B2 · Nojoomi et al. · 2024 [cited by applicant]
US 20020022832A1 · Mikus et al. · 2002 [cited by applicant]
US 20030130650A1 · Yaron · 2003 [cited by examiner]
US 20040024392A1 · Lewis et al. · 2004 [cited by applicant]
US 20040215180A1 · Starkebaum et al. · 2004 [cited by applicant]
US 20050107736A1 · Landman et al. · 2005 [cited by applicant]
US 20050251121A1 · Swanson · 2005 [cited by examiner]
US 20060122590A1 · Bliweis et al. · 2006 [cited by applicant]
US 20060211914A1 · Hassler, Jr. et al. · 2006 [cited by applicant]
US 20080255550A1 · Bell · 2008 [cited by applicant]
US 20080312644A1 · Fourkas et al. · 2008 [cited by applicant]
US 20090036823A1 · LePivert · 2009 [cited by applicant]
US 20090143759A1 · Van Dam et al. · 2009 [cited by applicant]
US 20090143760A1 · Van Dam et al. · 2009 [cited by applicant]
US 20090157002A1 · Dumot et al. · 2009 [cited by applicant]
US 20090192505A1 · Askew et al. · 2009 [cited by applicant]
US 20100094270A1 · Sharma · 2010 [cited by applicant]
US 20100179526A1 · Lawrence · 2010 [cited by applicant]
US 20110071350A1 · Van Dam et al. · 2011 [cited by applicant]
US 20110125143A1 · Gross et al. · 2011 [cited by applicant]
US 20120089047A1 · Ryba et al. · 2012 [cited by applicant]
US 20120109119A1 · Lalonde · 2012 [cited by applicant]
US 20120136343A1 · Burnett · 2012 [cited by applicant]
US 20120143298A1 · Just et al. · 2012 [cited by applicant]
US 20120197245A1 · Burnett et al. · 2012 [cited by applicant]
US 20120289880A1 · Van Dam et al. · 2012 [cited by applicant]
US 20130012938A1 · Asirvatham et al. · 2013 [cited by applicant]
US 20130030410A1 · Drasler et al. · 2013 [cited by applicant]
US 20130103020A1 · Levin · 2013 [cited by applicant]
US 20130144322A1 · Callaghan et al. · 2013 [cited by applicant]
US 20130218149A1 · Braun et al. · 2013 [cited by applicant]
US 20140180248A1 · Salik · 2014 [cited by applicant]
US 20140243780A1 · Leschinsky et al. · 2014 [cited by applicant]
US 20140277428A1 · Skemp et al. · 2014 [cited by applicant]
US 20140358089A1 · Kappel et al. · 2014 [cited by applicant]
US 20140358136A1 · Kelly et al. · 2014 [cited by applicant]
US 20150018808A1 · Mihalik · 2015 [cited by applicant]
US 20150148738A1 · Caplan et al. · 2015 [cited by applicant]
US 20150164571A1 · Saadat · 2015 [cited by applicant]
US 20150272666A1 · Wang · 2015 [cited by applicant]
US 20150342669A1 · Flanagan · 2015 [cited by examiner]
US 20160008050A1 · Rajagopalan et al. · 2016 [cited by applicant]
US 20160022346A1 · Shadduck · 2016 [cited by applicant]
US 20160038212A1 · Ryba et al. · 2016 [cited by applicant]
US 20160067465A1 · Gerrans · 2016 [cited by examiner]
US 20160302762A1 · Stigall et al. · 2016 [cited by applicant]
US 20170072173A1 · Van Dam et al. · 2017 [cited by applicant]
US 20170265924A1 · Kochavi · 2017 [cited by applicant]
US 20180014868A1 · O'Connor et al. · 2018 [cited by applicant]
US 20180028250A1 · O'Connor · 2018 [cited by applicant]
US 20180036058A1 · Fan et al. · 2018 [cited by applicant]
US 20180168710A1 · Ingle et al. · 2018 [cited by applicant]
US 20190328437A1 · Perron et al. · 2019 [cited by applicant]
US 20200275968A1 · McGregor et al. · 2020 [cited by applicant]
US 20200297403A1 · Kochavi · 2020 [cited by applicant]
US 20200360670A1 · Legum · 2020 [cited by examiner]
US 20210169545A1 · Hareland · 2021 [cited by applicant]
US 20220401145A1 · Nojoomi et al. · 2022 [cited by applicant]
US 20230090573A1 · Legum et al. · 2023 [cited by applicant]
US 20230135845A1 · Coulombe · 2023 [cited by applicant]
US 20230218332A1 · Nojoomi et al. · 2023 [cited by applicant]
US 20250170373A1 · Legum et al. · 2025 [cited by applicant]
US 20250221754A1 · Nojoomi et al. · 2025 [cited by applicant]
CN 101309651A · 2008 [cited by applicant]
CN 201743767U · 2011 [cited by applicant]
CN 103118613A · 2013 [cited by applicant]
CN 103221089A · 2013 [cited by applicant]
CN 105283141A · 2016 [cited by applicant]
CN 106102816A · 2016 [cited by applicant]
CN 109091176A · 2018 [cited by applicant]
EP 2252228B1 · 2016 [cited by applicant]
GB 2064082A · 1981 [cited by applicant]
JP H03126446A · 1991 [cited by applicant]
JP H049150A · 1992 [cited by applicant]
JP H04501821A · 1992 [cited by applicant]
JP H07500513A · 1995 [cited by applicant]
JP H07503627A · 1995 [cited by applicant]
JP 2007500545A · 2007 [cited by applicant]
JP 2010531178A · 2010 [cited by applicant]
JP 2020503097A · 2020 [cited by applicant]
JP 2020518305A · 2020 [cited by applicant]
WO WO2007001981A2 · 2007 [cited by applicant]
WO WO2011142909A1 · 2011 [cited by applicant]
WO WO2012071031A1 · 2012 [cited by applicant]
WO WO2014197444A1 · 2014 [cited by applicant]
WO WO2018044985A1 · 2018 [cited by applicant]
WO WO2018106688A2 · 2018 [cited by applicant]
WO WO2018142411A1 · 2018 [cited by applicant]
WO WO2019055800A1 · 2019 [cited by applicant]
WO WO2019157221A1 · 2019 [cited by applicant]
WO WO2021026467A1 · 2021 [cited by applicant]
WO WO2022036250A1 · 2022 [cited by applicant]
WO WO2022066873A1 · 2022 [cited by applicant]
WO WO2023130069A2 · 2023 [cited by applicant]
WO WO2023154886A1 · 2023 [cited by applicant]
WO WO2024148351A1 · 2024 [cited by applicant]
Extended European Search Report for European Application No. 19750455.8, mailed Nov. 18, 2021, 9 pages. [cited by applicant]
Extended European Search Report for European Application No. 21856812.9 mailed Aug. 21, 2024, 9 pages. [cited by applicant]
First Office Action and Search Report for Chinese Application No. 202180055403.4 mailed Aug. 9, 2025, with English translation, 20 pages. [cited by applicant]
First Office Action for Chinese Application No. 201980023912.1, mailed Apr. 24, 2022, with English translation, 20 pages. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2024/010655 mailed Jul. 17, 2025, 9 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2019/017112, mailed Jun. 14, 2019, 11 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2020/045436, mailed Jan. 21, 2021, 15 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2021/045987, mailed Nov. 29, 2021, 12 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2023/062419 mailed Jul. 28, 2023, 18 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2024/010655, mailed Apr. 10, 2024, 11 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2025/037388, mailed Sep. 30, 2025, 18 pages. [cited by applicant]
Invitation to Pay Additional Fees, Communication Relating to the Results of the Partial International Search and Provisional Opinion for International Application No. PCT/US2020/045436, mailed Nov. 5, 2020, 10 pages. [cited by applicant]
Invitation to Pay Additional Fees, Communication Relating to the Results of the Partial International Search and Provisional Opinion for International Application No. PCT/US2023/062419, mailed Jun. 7, 2023, 13 pages. [cited by applicant]
Notice of Allowance for Chinese Application No. 201980023912.1, mailed Dec. 14, 2022, with English translation, 7 pages. [cited by applicant]
Notice of Reasons for Refusal for Japanese Application No. 2022-506913 mailed Mar. 29, 2024, with English translation, 14 pages. [cited by applicant]
Notice of Reasons for Refusal for Japanese Application No. 2022-581352 mailed Aug. 12, 2025, with English translation, 12 pages. [cited by applicant]
Notice of Reasons for Rejection for Japanese Application No. 20200542754, dated Nov. 11, 2022, with English translation, 8 pages. [cited by applicant]
Notice of Reasons for Rejection for Japanese Application No. 2020-542754 dated May 31, 2023, with English translation, 4 pages. [cited by applicant]
Notice of Reasons for Rejection for Japanese Application No. 2020-542754 dated Nov. 20, 2023, with English translation, 4 pages. [cited by applicant]
Office Action for Australian Application No. 2019218889 dated Nov. 17, 2023, 3 pages. [cited by applicant]
Office Action for Canadian Application No. 3,090,658 dated Sep. 26, 2025, 5 pages. [cited by applicant]
Office Action for European Application No. 19750455.8 mailed Jun. 5, 2024, 7 pages. [cited by applicant]
Office Action for European Application No. 19750455.8 mailed Mar. 18, 2025, 7 pages. [cited by applicant]
Office Action for Mexican Application No. MX/a/2020/008362 dated Aug. 15, 2024, with English translation, 6 pages. [cited by applicant]
Office Action for Mexican Application No. MX/a/2020/008362 dated Feb. 6, 2024, with English translation, 9 pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/988,028, mailed Apr. 6, 2021, 19 pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/988,028, mailed Dec. 15, 2020, 21 pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/988,028, mailed Jan. 24, 2022, 23 pages. [cited by applicant]
Office Action for U.S. Appl. No. 17/865,469 dated Dec. 29, 2023, 26 pages. [cited by applicant]
Office Action for U.S. Appl. No. 17/865,469 mailed Mar. 24, 2023, 30 pages. [cited by applicant]
Office Action for U.S. Appl. No. 18/108,831 mailed Oct. 18, 2023, 36 pages. [cited by applicant]
Office Action for U.S. Appl. No. 18/757,398 mailed Apr. 24, 2025, 19 pages. [cited by applicant]
Japanese Application No. 2022-581352, Notice of Reasons for Refusal mailed Apr. 24, 2026; Applicant Ictero Medical, Inc.; with English translation, 9 pages. [cited by applicant]